The European Investment Bank (EIB) has signed an advisory agreement with Coalition for Epidemic Preparedness Innovations (CEPI) and its partners to support Covid-19 vaccine development across the world.

The agreement will also see the EIB and CEPI collaborate to improve how financial ecosystem’s pandemic preparedness, including looking at development of a new financing mechanism to mobilise capital.

EIB vice-president Ambroise Fayolle said: “Vaccine development is vital in the fight against global infections, including the current coronavirus pandemic.

“We are pleased to join forces with CEPI to jointly identify vaccine initiatives and suitable funding solutions to get these projects off the ground.

“The Bank offers numerous options for companies looking for funding to develop the next generation of vaccines in the search for solutions to global disease outbreaks.”

CEPI chief executive officer Dr Richard Hatchett added: “The Covid-19 pandemic presents the world with an unprecedented challenge.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Developing a vaccine that is available to all is going to be the world’s best exit strategy from this crisis, protecting lives and allowing societies to return to normal.

“I am very pleased to be partnering with the EIB which will help us in our work to develop a vaccine against this deadly disease.”